
Dynavax Technologies Corporation (0IDA.L)
0IDA.L Stock Price Chart
Explore Dynavax Technologies Corporation interactive price chart. Choose custom timeframes to analyze 0IDA.L price movements and trends.
0IDA.L Company Profile
Discover essential business fundamentals and corporate details for Dynavax Technologies Corporation (0IDA.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
IPO Date
29 Jan 2018
Employees
405.00
Website
https://www.dynavax.comCEO
Ryan Spencer
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.
0IDA.L Financial Timeline
Browse a chronological timeline of Dynavax Technologies Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 18 Feb 2026
Upcoming earnings on 5 Nov 2025
Upcoming earnings on 4 Aug 2025
Revenue estimate is $87.55M.
Earnings released on 6 May 2025
EPS came in at -$0.77 falling short of the estimated $0.03 by -2.78K%, while revenue for the quarter reached $68.16M, missing expectations by -19.00%.
Earnings released on 20 Feb 2025
EPS came in at $0.05 surpassing the estimated $0.04 by +10.11%, while revenue for the quarter reached $72.03M, missing expectations by -0.92%.
Earnings released on 8 Nov 2024
EPS came in at $0.12 surpassing the estimated $0.11 by +5.91%, while revenue for the quarter reached $80.63M, beating expectations by +12.43%.
Earnings released on 7 Aug 2024
EPS came in at $0.07 surpassing the estimated $0.06 by +14.21%, while revenue for the quarter reached $73.80M, missing expectations by -2.96%.
Earnings released on 9 May 2024
EPS came in at -$0.07 falling short of the estimated -$0.02 by -184.17%, while revenue for the quarter reached $50.79M, missing expectations by -7.61%.
Earnings released on 4 Mar 2024
EPS came in at $0.00 surpassing the estimated -$0.01 by +115.53%, while revenue for the quarter reached $55.60M, beating expectations by +5.44%.
Earnings released on 3 Nov 2023
EPS came in at $0.09 surpassing the estimated -$0.04 by +345.47%, while revenue for the quarter reached $69.51M, beating expectations by +15.28%.
Earnings released on 4 Aug 2023
EPS came in at $0.03 surpassing the estimated -$0.09 by +128.72%, while revenue for the quarter reached $60.25M, beating expectations by +24.50%.
Earnings released on 3 May 2023
EPS came in at -$0.19 falling short of the estimated -$0.13 by -43.55%, while revenue for the quarter reached $46.93M, beating expectations by +21.62%.
Earnings released on 24 Feb 2023
EPS came in at $0.45 surpassing the estimated $0.41 by +8.43%, while revenue for the quarter reached $184.49M, beating expectations by +2.72%.
Earnings released on 30 Sept 2022
EPS came in at $0.42 surpassing the estimated $0.30 by +41.93%, while revenue for the quarter reached $167.74M, beating expectations by +5.22%.
Earnings released on 30 Jun 2022
EPS came in at $0.86 surpassing the estimated $0.23 by +277.58%, while revenue for the quarter reached $256.46M, beating expectations by +69.85%.
Earnings released on 31 Mar 2022
EPS came in at $0.22 falling short of the estimated $0.28 by -21.79%, while revenue for the quarter reached $113.99M, missing expectations by -26.12%.
Dividend declared on 15 Mar 2022
A dividend of $0.29 per share was announced, adjusted to $0.29.
Earnings released on 23 Feb 2022
EPS came in at $0.77 surpassing the estimated $0.64 by +20.94%, while revenue for the quarter reached $195.07M, missing expectations by -6.61%.
Earnings released on 4 Nov 2021
EPS came in at $0.03, while revenue for the quarter reached $52.77M.
Earnings released on 30 Sept 2021
EPS came in at -$0.24, while revenue for the quarter reached $105.87M.
Earnings released on 31 Mar 2021
EPS came in at $0.01, while revenue for the quarter reached $83.34M.
Earnings released on 31 Dec 2020
EPS came in at -$0.14, while revenue for the quarter reached $13.25M.
Earnings released on 30 Sept 2020
EPS came in at $0.04, while revenue for the quarter reached $13.41M.
0IDA.L Stock Performance
Access detailed 0IDA.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.